Stay updated on Immuno-Therapy BMS-986178 in Solid Cancers Clinical Trial
Sign up to get notified when there's something new on the Immuno-Therapy BMS-986178 in Solid Cancers Clinical Trial page.

Latest updates to the Immuno-Therapy BMS-986178 in Solid Cancers Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error. Its footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating that access to the content is restricted and only a basic header/footer is shown.SummaryDifference23%

- Check55 days agoChange DetectedThe page revision label updated from v3.6.5 to v3.6.6, indicating a new release of the page's metadata. This is an administrative change and does not modify study content or functionality.SummaryDifference0.0%

- Check62 days agoChange DetectedAn NIH grant/contract entry has been added to the study's identifiers, recording funding attribution for the trial. This update adds context about funding without altering the study design or participant-facing information.SummaryDifference0.0%

- Check76 days agoChange DetectedA new page revision label Revision: v3.6.5 appears, signaling an update to the study record. The Investigator Inquiry Form was removed, and the previous Revision: v3.6.4 entry was deleted from the page.SummaryDifference0.1%

Stay in the know with updates to Immuno-Therapy BMS-986178 in Solid Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immuno-Therapy BMS-986178 in Solid Cancers Clinical Trial page.